- Home
- GNK vs MBX Comparison
GNK vs MBX Comparison
Compare GNK & MBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNK
- MBX
- Stock Information
- Founded
- GNK 2004
- MBX 36
- Country
- GNK United States
- MBX United States
- Employees
- GNK N/A
- MBX N/A
- Industry
- GNK Marine Transportation
- MBX
- Sector
- GNK Consumer Discretionary
- MBX
- Exchange
- GNK Nasdaq
- MBX NYSE
- Market Cap
- GNK 707.2M
- MBX 644.6M
- IPO Year
- GNK 2005
- MBX 2024
- Fundamental
- Price
- GNK $14.03
- MBX $19.90
- Analyst Decision
- GNK Strong Buy
- MBX Strong Buy
- Analyst Count
- GNK 6
- MBX 4
- Target Price
- GNK $24.20
- MBX $37.25
- AVG Volume (30 Days)
- GNK 463.9K
- MBX 167.8K
- Earning Date
- GNK 11-06-2024
- MBX 11-07-2024
- Dividend Yield
- GNK 11.27%
- MBX N/A
- EPS Growth
- GNK 527.82
- MBX N/A
- EPS
- GNK 1.58
- MBX N/A
- Revenue
- GNK $439,330,000.00
- MBX N/A
- Revenue This Year
- GNK $7.51
- MBX N/A
- Revenue Next Year
- GNK N/A
- MBX N/A
- P/E Ratio
- GNK $8.79
- MBX N/A
- Revenue Growth
- GNK 11.14
- MBX N/A
- 52 Week Low
- GNK $13.91
- MBX $15.31
- 52 Week High
- GNK $23.43
- MBX $27.50
- Technical
- Relative Strength Index (RSI)
- GNK 23.14
- MBX N/A
- Support Level
- GNK $14.80
- MBX N/A
- Resistance Level
- GNK $15.89
- MBX N/A
- Average True Range (ATR)
- GNK 0.42
- MBX 0.00
- MACD
- GNK -0.14
- MBX 0.00
- Stochastic Oscillator
- GNK 4.30
- MBX 0.00
About GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, the ocean transportation of drybulk cargoes through the ownership and operation of drybulk carrier vessels. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters.
About MBX MBX BIOSCIENCES INC
MBX Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.